OpenAlex
PricingAboutJobs
Log inGet started
Work

Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations?

HTML

Year: 2019
Type: review
Source: Pharmacology & Therapeutics
DOI: 10.1016/j.pharmthera.2019.107450
Authors: Alice Bradbury, Sally Hall, Nicola Curtin, Yvette Drew
Institutions: Newcastle University, Newcastle upon Tyne Hospitals NHS Foundation Trust
Language: English

Topic: PARP inhibition in cancer therapy
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ATR inhibitors, synthetic lethality, DNA damage response, replication stress, PARP inhibitors, combination therapy, chemotherapy, radiotherapy, biomarkers, patient selection, clinical trials, anticancer drug development
SDG: Good health and well-being

Open Access status: green

Funders: Cancer Research UK, Medical Research Council
Awards: G26675529, Understanding synthetic lethality of ATR inhibitors with DDR dysregulation common in ovarian cancer
OpenAlex ID: W2995953807
FWCI: 2.171
Cites: 131
Cited by: 189
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms